对于耐火性心室动脉动脉动症患者的心脏切除的SBRT
Morgan Vozzolo1, Kylie Giller1
1Morgan Vozzolo, R.T.(T), and Kylie Giller, R.T.(T), work at Hartford Hospital in Hartford, Connecticut.
Radiologic technology
|May 8, 2024
概括
立体性身体辐射疗法 (SBRT) 为患有治疗阻断性心室动脉动脉障 (VT) 的患者提供了一个新的选择. 这项案例研究表明,SBRT有效地减少了静脉动脉发作和改善了患者的幸福感,这表明对耐性心律不整的管理有希望.
科学领域:
- 心脏病学 心脏病学
- 辐射瘤学 辐射瘤学
- 医学物理 医学物理
背景情况:
- 一名44岁的男性患有末期缺血性心肌病,经历了耐火性心室性心力衰竭 (VT).
- 尽管先前的干预措施包括植入式心脏转换器-除器,两次静脉动脉切除和药物治疗,但患者继续出现静脉动脉发作.
- 对于末期静脉瘤存在有限的治疗选择.
研究的目的:
- 评估立体性全身辐射疗法 (SBRT) 在治疗不耐用的静脉瘤患者减轻静脉瘤负担方面的疗效.
- 评估心脏SBRT作为一种新的治疗方法的安全性和短期结果.
主要方法:
- 患者接受了针对心脏的立体体辐射疗法 (SBRT).
- 施加的辐射剂量为25 Gy到右下侧区域和15 Gy到心脏的下部.
- 这种非侵入性门诊手术是在传统治疗失败后进行的.
主要成果:
- 在SBRT治疗后一个月,患者报告说能量水平有所改善.
- 在SBRT治疗后的一个月内,没有发生心室低心率 (VT) 发作.
- 患者经历了心律失常负担显著降低.
结论:
- 心脏SBRT是一种新且潜在有效的治疗方法,用于对标准疗法耐药的心室性心力衰竭 (VT) 患者.
- 这项案例研究表明,SBRT能够减少心律失常并改善患者报告的结果.
- 虽然长期结果尚不清楚,但SBRT对于治疗不耐药的静脉瘤患者来说是一个有利的选择.
相关概念视频
Disturbances in Heart Rhythm
945
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
945
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
830
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
830


